Your browser doesn't support javascript.
loading
Effect of IL-6 on alveolar fibroblast proliferation in interstitial lung diseases.
Shahar, I; Fireman, E; Topilsky, M; Grief, J; Kivity, S; Spirer, Z; Ben Efraim, S.
Afiliación
  • Shahar I; Department of Pulmonary Diseases and Allergy Center, Tel-Aiv Medical Center, Israel.
Clin Immunol Immunopathol ; 79(3): 244-51, 1996 Jun.
Article en En | MEDLINE | ID: mdl-8635282
ABSTRACT
Alveolar macrophage-fibroblast interaction may be involved in the pathogenesis of interstitial lung diseases (ILD). Herein, we compared IL-6 secretion from alveolar macrophages (AM) and alveolar fibroblasts (AFb) recovered from patients with sarcoidosis (SA) and with diffuse interstitial fibrosis (DIF). Moreover, we evaluated the effect of IL-6 on the in vitro AFb proliferation in both diseases. AM and AFb from SA patients showed increased spontaneous secretion of IL-6 compared with cells from DIF subjects. Tumor necrosis factor-alpha (TNFalpha) and interleukin-1 (IL-1) enhanced IL-6 secretion and IL-6 mRNA transcription in AFb of SA patients. Addition of anti-IL-6 MoAbs increased AFb proliferation capacity in SA, but suppressed it in DIF. These results show that only SA AM and AFb secrete high levels of IL-6 which have suppressive effect on AFb proliferation. This may indicate a potential role of IL-6 in the fibrogenesis of ILD.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alveolos Pulmonares / Interleucina-6 / Enfermedades Pulmonares Intersticiales Límite: Humans Idioma: En Revista: Clin Immunol Immunopathol Año: 1996 Tipo del documento: Article País de afiliación: Israel
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alveolos Pulmonares / Interleucina-6 / Enfermedades Pulmonares Intersticiales Límite: Humans Idioma: En Revista: Clin Immunol Immunopathol Año: 1996 Tipo del documento: Article País de afiliación: Israel